Lyndra Therapeutics is pioneering the first-ever oral, ultra-long-acting, sustained-release therapies, which have the potential to fundamentally change the way people take medicine by enabling patients to take a pill once a week rather than daily.
REVOLUTION Medicines
19 followers
Rigel Pharmaceuticals
5 followers
Biocytogen
5 followers
Bicara Therapeutics
2 followers
BAMF Health
2 followers
Cytek Biosciences
1 follower
Invivyd
1 follower
Asklepios BioPharmaceutical
2 followers
Alamar Biosciences, Inc.
2 followers
Alloy Therapeutics
2 followers
Biolinq
2 followers
Truveta
5 followers